AllogeneTherapeutics (ALLO) Downgradedby TheGoldmanSachsGroup,Inc. to Neutral

AllogeneTherapeutics} stock has undergone multiple analysts rating changes in the recent past.  AllogeneTherapeutics Downgradedby TheGoldmanSachsGroup,Inc. on 10-08-21. In a note to investors, the firm issued a new rating of Neutral. The analysts previously had rating of Buy.

View More AllogeneTherapeutics (ALLO) Downgradedby TheGoldmanSachsGroup,Inc. to Neutral

AllogeneTherapeutics (ALLO) Downgradedby StifelNicolaus to Hold

AllogeneTherapeutics} stock has undergone multiple analysts rating changes in the recent past.  AllogeneTherapeutics Downgradedby StifelNicolaus on 10-08-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More AllogeneTherapeutics (ALLO) Downgradedby StifelNicolaus to Hold